Form 8-K - Current report:
SEC Accession No. 0000950170-24-129357
Filing Date
2024-11-20
Accepted
2024-11-20 16:42:31
Documents
21
Period of Report
2024-11-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hcwb-20241118.htm   iXBRL 8-K 57267
2 EX-4.1 hcwb-ex4_1.htm EX-4.1 153788
3 EX-4.2 hcwb-ex4_2.htm EX-4.2 138655
4 EX-5.1 hcwb-ex5_1.htm EX-5.1 73711
5 EX-10.1 hcwb-ex10_1.htm EX-10.1 124263
6 EX-10.2 hcwb-ex10_2.htm EX-10.2 370294
7 EX-99.1 hcwb-ex99_1.htm EX-99.1 14992
8 EX-99.2 hcwb-ex99_2.htm EX-99.2 19737
9 GRAPHIC img90053791_0.jpg GRAPHIC 53569
10 GRAPHIC img90977312_0.jpg GRAPHIC 53569
11 GRAPHIC img199955712_0.jpg GRAPHIC 44816
  Complete submission text file 0000950170-24-129357.txt   1440513

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hcwb-20241118.xsd EX-101.SCH 25994
23 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20241118_htm.xml XML 4928
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

EIN.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40591 | Film No.: 241480963
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)